GlassScriptPhysician profile
Peter A Rasmussen
NPI 1902860984
$57,947.57
in general payments reported to CMS, 2019-2025
19 companies · $1,189 in 2025
The $1,189 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $73.06 · 2021: $1,203 · 2022: $11K · 2023: $1,343 · 2024: $42K · 2025: $1,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Food and Beverage: $4,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,000.00 |
| Food and Beverage | $4,154.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centerline Biomedical INC. | $50,303.07 | 2022-2025 | |
| Stryker Corporation | $1,732.43 | 2019-2025 | Target, Trevo, Axsos |
| Medtronic, INC. | $1,599.43 | 2021-2025 | Pipeline, Onyx 18 |
| Penumbra, INC. | $891.30 | 2019-2025 | Red 72, Penumbra System, Penumbra Coil 400 |
| Route 92 Medical, INC. | $671.33 | 2021-2025 | 8f Base Camp Sheath System |
| Corindus INC. | $639.25 | 2019 | |
| Microvention, INC. | $509.46 | 2019-2024 | Azur Cx Detachable, Web Aneurysm Embolization System, Lvis Junior |
| Masimo Corporation | $300.02 | 2023 | Hm 38-02 Assembly, Na |
| Viz.Ai, INC. | $250.54 | 2021 | |
| Imperative Care, INC | $169.57 | 2025 | Zoom 88-T Large Distal Platform |
| Qapel Medical INC | $163.10 | 2025 | |
| Abbott Laboratories | $135.58 | 2024 | Dragonfly Opstar |
| Medtronic USA, INC. | $120.71 | 2019-2020 | |
| Contego Medical, INC | $104.68 | 2024 | |
| Depuy Synthes Sales INC. | $99.88 | 2023 | Trufill |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scientia Vascular | $79.93 | 2022 | |
| Boston Scientific Corporation | $71.40 | 2022 | |
| Cardiva Medical, INC. | $67.89 | 2022-2024 | Cardiva Vascade 6/7f Vcs |
| Omniscient Neurotechnology America LTD | $38.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$144,480.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Rasmussen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.